Investors Target Insulet Corporation in Class Action Suit
A class action lawsuit now targets Insulet Corporation, alleging the manufacturer of insulin delivery systems misled shareholders regarding the reliability of its production lines. The litigation follows a series of voluntary product corrections that triggered significant drops in the company’s share price throughout early 2026.